Poland· PL-100476429
Depakine
A valproic acid product containing natrii valproas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Valproic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Valproic acid · ATC N03AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valproic acid costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Valproic acid · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.61
The record
At a glance
URPL (Poland)- Active substance
- Natrii valproas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N03AG01
- ATC class
- Valproic acid
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991501495
- gtin05909991501501
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
391 interactions on record for valproic acid.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valproic acid · interactions on record
391 records
- 9 severe
- 132 moderate
- 23 minor
- 189 info
Most severe, free to view
- Glycerol phenylbutyrateA16AX09severe
- BexaroteneL01XF03severe
- VorinostatL01XH01severe
- BexarotenL01XX25severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valproic acid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDepakin 200mg/ml oral solutionImported (Italy)
- CzechiaCONVULEXG.L. Pharma GmbH, Lannach
- FinlandAbsenorParanova Oy
- SwedenAbsenor 100 mg EnterotablettOrion Corporation
- United StatesDivalproex SodiumHahnemann Laboratories, INC.
- GermanyErgenylSanofi-Aventis Deutschland Gmbh
- BelgiumConvulex Retard 300 mgG.L. Pharma
- NorwayDeprakine RetardSanofi-aventis
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Convulex, Convulex Für Kinder
- Belgium · Depakine, Depakine Enteric
- Bulgaria · Convulex Chrono, Депакин
- Cyprus · Depakine, Epixival
- Czechia · Convulex, Convulex Cr
- Germany · Ergenyl, Ergenyl Intravenös
- Denmark · Delepsine, Delepsine Retard
- Estonia · Convulex, Convulex Retard
- Spain · Ácido Valproico Altan Pharmaceuticals, S.A., Acido Valproico Seacross
- Finland · Absenor, Orfiril
- France · Depakine, L.P.
- United Kingdom (Northern Ireland) · Epilim, Episenta
- Greece · Depakine, Hexaquin
- Croatia · Convyval
- Hungary · Convulex, Convulex Gyermekeknek
- Ireland · Epilim, Epilim Enteric
- Iceland · Orfiril, Orfiril Retard
- Italy · Acido Valproico Sandoz, Depakin
- Lithuania · Convulex, Convulex Retard
- Luxembourg · Depakine, Depakine Enteric
- Latvia · Convulex, Convulex Retard
- Malta · Epilim Liquid
- Netherlands · Depakine Enteric, Depakine I.V.
- Norway · Orfiril, Orfiril Long
- Portugal · Ácido Valpróico Generis, Depakine
- Romania · Depakine, Orfiril Long
- Sweden · Absenor, Absenor Depot
- Slovenia · Convyval
- Slovakia · Convulex, Convulex Cr
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee2d1881-aa51-4d54-aba8-216e56684037 GET /v1/drugs/ee2d1881-aa51-4d54-aba8-216e56684037?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "400 mg (400 mg/4 ml)",
"packaging": "05909991501495 ¦ Lz ¦ 147713\n1 fiolka z proszkiem i 1 ampułka z rozpuszczalnikiem 4 ml\n05909991501501 ¦ Lz ¦ 147714\n4 fiolki z proszkiem i 4 ampułki z rozpuszczalnikiem po 4 ml.",
"substance": "Natrii valproas 400 mg (400 mg/4 ml)",
"common_name": "Natrii valproas",
"pl_product_id": "100476429",
"pozwolenie_nr": "412/22",
"auth_procedure": "IR",
"authorisation_validity": "2027-11-22"
}See everything about valproic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.